AccelRX.ai
AC
AC

AccelRX.ai

AccelRx.ai is an AI agent that runs the full prior-authorization workflow for specialty clinics, chart intake, policy research, form fill,

2022InactiveSan Francisco, United States

About

Prior authorization is the largest operational tax on specialty prescribing : every case takes 30-60 minutes of clinic staff time, approval rates suffer because chart-to-policy fit goes unresearched, and denials trigger a paper-based appeal cycle that frequently gets abandoned. AccelRx.ai is an AI agent that runs the entire PA workflow autonomously. It reads the chart note, matches the payer-specific coverage policy, fills the CoverMyMeds form using clinical evidence pulled from the chart, submits to the payer, and drafts an appeal letter when denied by citing the patient's actual chart and the payer's own published criteria.

Key facts

Website
accelrx.ai
Headquarters
San Francisco, United States
Founded
2022
Total funding
$2M (Seed)
Valuation
Private
Business model
B2B
Tags
AI Agents
HealthTech
Workflow Automation
Revenue Cycle Management
Clinical Operations

Funding rounds

Funding rounds raised by AccelRX.ai
DateRoundAmountLead investors
1 Jan 2023Seed$2MHealthTech Ventures

Tech stack

Detected on accelrx.ai, last scanned 3 Jul 2026. Run your own scan

Compliance
SOC 2, HIPAA
Frontend
Next.js, Tailwind CSS
Hosting
Google Cloud
Email provider
Google Workspace
Add first review

Frequently asked

How much funding has AccelRX.ai raised?

AccelRX.ai has raised a total of $2M in funding. The most recent round on record is Seed.

What is AccelRX.ai's current status?

AccelRX.ai's current operating status is: Inactive.